[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2005/209260,2005,A1Locationinpatent:Page/Pagecolumn137
[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US2007/49609,2007,A1Locationinpatent:Page/Pagecolumn118
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2005/209260,2005,A1Locationinpatent:Page/Pagecolumn105
[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US2007/49609,2007,A1Locationinpatent:Page/Pagecolumn96
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2005/209260,2005,A1Locationinpatent:Page/Pagecolumn137
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2005/209260,2005,A1Locationinpatent:Page/Pagecolumn122
[1]CurrentPatentAssignee:ROCHEHOLDINGAG-US2005/209260,2005,A1Locationinpatent:Page/Pagecolumn95-96
[2]CurrentPatentAssignee:ROCHEHOLDINGAG-US2007/49609,2007,A1Locationinpatent:Page/Pagecolumn87-88
[3]CurrentPatentAssignee:MERCK&COINC-US2015/57299,2015,A1Locationinpatent:Paragraph0155;0156
[4]CurrentPatentAssignee:MERCK&COINC-WO2016/4358,2016,A1Locationinpatent:Paragraph185
[5]CurrentPatentAssignee:ROCHEHOLDINGAG-US2007/49758,2007,A1Locationinpatent:Page/Pagecolumn31-32
[6]CurrentPatentAssignee:ROCHEHOLDINGAG-US2007/49751,2007,A1Locationinpatent:Page/Pagecolumn19-21
Title: AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.
Journal: British journal of pharmacology 20100701
Title: Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
Journal: Bioorganic & medicinal chemistry letters 20090315
Title: Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
Journal: Bioorganic & medicinal chemistry letters 20090315
Title: Gever JR, et al. AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Br J Pharmacol. 2010 Jul;160(6):1387-1398.
Title: Munoz A, et al. Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3receptors. BJU Int. 2012 Oct;110(8 Pt B):E409-414.